Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: H. Lundbeck A/S, Ottilavaj 9, 2500 Valby, Denmark
CIPRALEX 20 mg/ml oral drops, solution.
| Pharmaceutical Form |
|---|
|
Oral drops, solution. Clear, nearly colourless to yellowish solution with a bitter taste. |
Each ml of solution contains: 20 mg escitalopram (as 25.551 mg escitalopram oxalate).
Each drop contains 1 mg escitalopram.
Excipients with known effect: each drop contains 4.7 mg ethanol.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Escitalopram is a selective inhibitor of serotonin (5-HT) re-uptake with high affinity for the primary binding site. It also binds to an allosteric site on the serotonin transporter, with a 1000 fold lower affinity. The inhibition of 5-HT re-uptake is the only likely mechanism of action explaining the pharmacological and clinical effects of escitalopram. |
| List of Excipients |
|---|
|
Propyl gallate |
15 ml in a brown glass bottle with dropper applicator (polyethylene), and child-proof screw cap (polypropylene).
H. Lundbeck A/S, Ottilavaj 9, 2500 Valby, Denmark
PL 13761/0028
Date of first authorisation: 03 January 2008
Date of latest renewal: 11 December 2011
| Drug | Countries | |
|---|---|---|
| CIPRALEX | Austria, Canada, Cyprus, Germany, Estonia, Spain, Finland, Croatia, Israel, Italy, Lithuania, Malta, Romania, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.